|
|
||||||||
1 Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine, Grand Forks, 58203; and 2 Grand Forks Human Nutrition Research Center, Agricultural Research Service, United States Department of Agriculture, Grand Forks, North Dakota 58202
| |
ABSTRACT |
|---|
|
|
|---|
Dietary copper deficiency leads to cardiac hypertrophy, cardiac fibrosis, derangement of myofibrils, and impaired cardiac contractile and electrophysiological function. The purpose of this study was to determine whether impaired cardiac function from copper deficiency is due to depressed contractile function at the single myocyte level. Male Sprague-Dawley rats were fed diets that were either copper adequate (5.59-6.05 µg copper/g body wt; n = 11) or copper deficient (0.29-0.34 µg copper/g body wt; n = 11) for 5 wk. Ventricular myocytes were dispersed and mechanical properties were evaluated using the SoftEdge video-based edge-detection system. Intracellular Ca2+ transients were examined using fura 2-acetoxymethyl ester. Myocytes were electrically stimulated to contract at 0.5 Hz. Properties evaluated included peak shortening (PS), time to peak shortening (TPS), time to 90% relengthening (TR90), and maximal velocities of shortening and relengthening (±dL/dt). Myocytes from the copper-deficient rat hearts exhibited significantly enhanced PS values associated with shortened TR90 measurements compared with those from copper-adequate rat hearts. The ±dL/dt values were enhanced and the intracellular Ca2+ transient decay rate was depressed in myocytes from copper-deficient rats. These data indicate that impaired cardiac contractile function that is seen in copper-deficient whole hearts might not be due to depressed cardiac contractile function at the single cell level but rather to other mechanisms such as cardiac fibrosis.
cardiac; intracellular Ca2+ transients
| |
INTRODUCTION |
|---|
|
|
|---|
COPPER IS A COFACTOR in over 20 enzymes in the body, including lysyl oxidase, copper/zinc superoxide dismutase, and ceruloplasmin (17). Through these enzymes copper may contribute to the normal function of the heart. Deficiency of this important cation has been implicated in a number of cardiovascular disorders such as cardiac hypertrophy, abnormal electrocardiograms, cardiac fibrosis, distorted cardiac myofibrils, and an increase in the heart mitochondria volume fraction (see Ref. 26 for review). Copper deficiency causes concentric enlargement of the heart (11, 15) that occurs in both the atria and ventricles (13). Connective tissue of these hearts is also altered in copper deficiency (27) as is suggested upon gross examination by the presence of softened texture and ventricular aneurysms (19) and via microscopic study of changes in the structure of the basement membrane, perimysial and endomysial connective tissue (2, 4, 5), and valves (14).
Copper deficiency is also implicated in the impairment of energy
metabolism (26) presumably through the depression of
energy production by decreased oxidative phosphorylation. Huang and
colleagues (10) showed a depression of mRNA for
1- and
2-isoforms and protein levels of
the
2-isoform of Na+-K+-ATPase
in myocytes of copper-deficient rat hearts. Impairment of the transport
of Na+ and K+ could result in reduction of
cardiac function via a decrease in ion movement.
Cardiac contractile function as measured in the whole isolated heart is reduced by dietary copper deficiency (1, 18). However, studying the role of copper deficiency in cardiac electromechanical functions in multicellular preparations has limitations; because these preparations encompass a heterogeneous population of cells, functional changes of single myocytes may not be accurately represented. Thus the action of copper on cardiac electromechanical function may be influenced by nonmyocyte factors such as interstitial connective tissue or fibrous growth. For example, increased ventricular stiffness may reflect a greater amount of interstitial fibrosis and a shift in collagen content rather than a direct effect on the mechanical properties of myocytes specifically. In contrast, studies with isolated myocytes can utilize cell biological and biophysical techniques to evaluate the actions of copper in a homogeneous population of cells. To our knowledge, no study has utilized isolated cells to investigate the role of copper deficiency in ventricular contractile function. The aim of the present study was to determine the impact of copper deficiency on cardiac contractile function at the single myocyte level.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals and diets. All animal experimentation was conducted in accordance with humane animal care standards as outlined in the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-23, Revised 1996). The procedures were approved by the Animal Investigation Committee of the University of North Dakota and the Grand Forks Human Nutrition Research Center Animal Care Committee.
For this study, 22 male weanling Sprague-Dawley rats (Sasco; Lincoln, NE) were divided into two weight-paired groups and individually housed in stainless steel suspended cages in a room with controlled temperature (22 ± 1°C) and humidity (50 ± 4%) and a 12:12 h light-dark cycle. The rats were fed ad libitum either a copper-adequate (CuA) or copper-deficient (CuD) diet. Diet starting times were staggered to allow sufficient time for proper data collection and interpretation before proceeding to another animal; however, the duration of feeding was consistent between groups. Each kilogram of the CuA and CuD diets contained 940.0 g of copper-free and iron-free basal diet (TD-84469; Teklad Test Diets; Madison, WI), 50.0 g of safflower oil (Hollywood Foods; Los Angeles, CA), and 10.0 g of a copper-iron mineral mix. The basal diet included (in g/kg of diet) 200 casein, 386 sucrose, and 295 cornstarch and contained all known essential vitamins and minerals except for copper and iron (12). The copper-iron mineral mix contained cornstarch (Argo; CPC Food Service; Englewood Cliffs, NJ) and iron with or without copper, and provided 0.22 g of ferric citrate (16% iron; J. T. Baker Chemical; Phillipsburg, NJ) and either 0 or 24 mg of added CuSO4 · 5H2O (J. T. Baker Chemical) per kilogram of diet. These formulations were intended to provide a diet that contained copper only in the basal diet and thus was severely CuD, and a diet that contained 6 mg of copper per kilogram of diet and thus was CuA. Dietary analysis of six samples from each diet indicated that the copper concentration (described in the next paragraph) of the CuD diet was 0.29-0.34 mg/kg of diet, whereas the CuA diet contained 5.59-6.05 mg/kg of diet. Analysis of dietary copper was accomplished by obtaining dry ash of the diet sample (6), dissolving the ash in aqua regia, and measuring the copper quantity via atomic absorption spectroscopy (model 503; Perkin Elmer; Norwalk, CT). Validation of the assay method was provided by simultaneous assays of a wheat-flour reference standard [National Institute of Standards and Technology (NIST); Gaithersburg, MD] and a dietary reference standard (HNRC-1A) that was developed by the Grand Forks Human Nutrition Research Center. After 5 wk of consuming the respective diets, rats were anesthetized by injection of ketamine and xylazine in a 3:1 ratio (1.32 mg/kg body wt ip).Liver copper analysis. Livers were removed and snap-frozen in liquid nitrogen for subsequent assessment of copper content. Copper concentration was determined by lyophilizing and digesting liver samples with nitric acid and hydrogen peroxide (16) and measuring the copper content via inductively coupled argon plasma-emission spectroscopy (Fisons-ARL model 3560B; Thermo Jarrell Ash; Franklin, MA). Parallel assays of NIST reference samples (1477a, bovine liver) yielded values within the specified range thus validating our copper assay.
Isolation of ventricular myocytes. Single ventricular myocytes were isolated from CuA or CuD rat hearts as described previously (20). One animal was killed each day and the isolations were alternated between the control and experimental groups. In brief, hearts were rapidly removed and perfused (at 37°C) with oxygenated (5% CO2-95% O2) perfusion buffer that contained (in mM) 118 NaCl, 4.7 KCl, 1.25 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 10 HEPES, and 11.1 glucose (pH 7.4). Hearts were subsequently perfused with a nominally Ca2+-free perfusion buffer for 2-3 min (until spontaneous contractions ceased) and then were perfused for 20 min with Ca2+-free perfusion buffer containing 223 U/ml of collagenase (Worthington Biochemical; Freehold, NJ) and 0.1 mg/ml of hyaluronidase (Sigma Chemical; St. Louis, MO). After perfusion, the left ventricle was removed, minced, and incubated with fresh enzyme solution (Ca2+-free perfusion buffer containing 223 U/ml of collagenase) for 3-5 min. The cells were further digested with 0.02 mg/ml of trypsin (Sigma) before being filtered through a 300-µm nylon mesh and collected by centrifugation (60 g for 30 s). Myocytes were resuspended in a sterile filtered Ca2+-free perfusion buffer containing (in mM) 131 NaCl, 4 KCl, 1 MgCl2, 10 HEPES, and 10 glucose, supplemented with 2% BSA (pH 7.4; 37°C). Cells were initially washed with Ca2+-free perfusion buffer to remove remnant enzyme, and extracellular Ca2+ was added incrementally to achieve a 1.25 mM concentration. Isolated myocytes were maintained at 37°C in a serum-free medium consisting of medium 199 (Sigma) with Earle's balanced salts containing 25 mM HEPES and NaHCO3 supplemented with 2 mg/ml of BSA, 2 mM L-carnitine, 5 mM creatine, 5 mM taurine, 5 mM glucose, 0.1 µM insulin, 100 U/ml of penicillin, 100 mg/ml of streptomycin, and 100 mg/ml of gentamicin. Mechanical properties remained relatively stable in myocytes maintained for 12-24 h in the serum-free medium. Cells that had any obvious sarcolemmal blebs or spontaneous contractions were not used; only rod-shaped myocytes with distinctly clear edges were selected for recording of mechanical properties or intracellular Ca2+ transients as previously described (21).
Cell shortening and relengthening measurements.
Mechanical properties of ventricular myocytes were assessed using a
video-based edge-detection system (IonOptix; Milton, MA) as previously
described (20). In brief, coverslips with cells attached
were placed in a chamber mounted on the stage of an inverted microscope
(Olympus X-70) and superfused (~2 ml/min at 25°C) with a buffer
containing (in mM): 131 NaCl, 4 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, and 10 HEPES (pH 7.4). The cells were
field stimulated at a frequency of 0.5 Hz for 3 ms in duration using a
pair of platinum wires placed on opposite sides of the chamber
connected to an FHC stimulator (FHC; Brunswick, ME). The
polarity of the stimulating electrodes was reversed periodically to
avoid potential buildup of electrolysis byproducts. The myocyte being
studied was displayed on a computer monitor using an IonOptix MyoCam
camera, which rapidly scans the image area every 8.3 ms such that the amplitude and velocity of shortening or relengthening are recorded with
good fidelity. Changes in cell length (CL) during shortening and
relengthening were captured and converted into an analog voltage signal. Cell shortening and relengthening were assessed using indexes
of peak shortening (PS), time to 90% PS (TPS), time to 90%
relengthening (TR90), and maximal velocities of shortening (+dL/dt) and relengthening (
dL/dt),
respectively (21).
Ca2+ dose response. A separate cohort of cells from both the CuA and CuD groups was initially perfused with a perfusion buffer containing 0.5 mM CaCl2 for 10 min. The concentration of Ca2+ was increased to 1, 2, and 3 mM, and recordings of the same cell were taken at each of the doses to show the effect of increased extracellular Ca2+ on the contractile response of the cells. Cells were abandoned if spontaneous contractions developed at any time during this process.
Intracellular Ca2+ transient
measurement.
A separate group of myocytes was loaded with the
Ca2+-sensitive indicator fura 2-acetoxymethyl ester (fura
2-AM; 0.5 µmol/l; Molecular Probes; Eugene, OR) for 15 min at 25°C.
Fluorescence measurements were recorded with a dual-excitation
single-emission fluorescence photomultiplier system (IonOptix).
Myocytes were placed on an inverted microscope and imaged through an
Olympus Fluor ×40 oil objective. Myocytes were exposed to light
emitted by a 75-W halogen lamp through either a 360- or 380-nm filter while being stimulated to contract at 0.5 Hz. Fluorescence emissions were detected between 480 and 520 nm by a photomultiplier tube after
initial illumination at 360 nm for 0.5 s and then at 380 nm for
the duration of the recording protocol. The 360-nm excitation scan was
repeated at the end of the protocol and qualitative changes in the
intracellular Ca2+ concentration
([Ca2+]i) were inferred from the ratio of the
fura fluorescence intensity (FFI) at both wavelengths. The fluorescence
decay time (
) was also measured as an indication of the
intracellular Ca2+ clearing rate (20).
Data analysis. For each experimental series, data are presented as means ± SE. Statistical significance (P < 0.05) for each variable was estimated by two-way ANOVA or t-test where appropriate.
| |
RESULTS |
|---|
|
|
|---|
General features of CuA and CuD animals.
The CuD rats exhibited significantly lower body weights and liver
copper concentrations with significant cardiac and renal hypertrophy
and hepatomegaly compared with the age-matched CuA animals (see Table
1). When found in animals fed a CuD diet, these signs are regarded as evidence of copper deficiency
(24-26).
|
PS, TPS, and TR90 for cardiac myocytes isolated from
CuA and CuD animals.
There were no recognizable differences in myocyte yield,
field-stimulation threshold, spontaneous twitch, Ca2+
intolerance, or viability between the CuA and CuD groups. Approximately 20 cells were randomly selected for mechanical studies from each animal. Copper deficiency did not affect resting CL. The average resting CL values for ventricular myocytes used in this study were
163 ± 4 and 172 ± 5 µm in CuA (n = 223 cells/group from 11 animals) and CuD (n = 193 cells/group from 9 animals), respectively. The PS amplitude normalized
to CL was significantly enhanced in myocytes isolated from CuD hearts
(see Fig. 1A). Cells from the CuD group exhibited significantly enhanced changes in PS relative to
the CuA group (11.0 and 16.0% for CuA and CuD groups, respectively; see Fig. 1B). Myocytes under sustained copper deficiency
also exhibited a normal TPS value and significantly reduced
TR90 measurement (see Fig. 1, C and
D, respectively). The enhanced myocyte shortening and
reduced TR90 values are associated with significantly
enhanced +dL/dt and
dL/dt
(see Fig. 2).
|
|
Effect of stimulation frequency on myocyte shortening.
Rat hearts normally contract at very high frequencies (300 beats/min at
37°C), whereas our baseline studies were conducted at 0.5 Hz. To
assess for copper status-dependent differences in cardiac
excitation-contraction (E-C) coupling at higher frequencies, we
increased the stimulation frequency incrementally to 5 Hz (300 beats/min) and recorded steady-state PS. Cells maintained at 25°C were initially stimulated to contract at 0.5 Hz for 5 min to ensure that steady state was attained before the frequency study was started.
Figure 3 shows a negative staircase
effect in PS with increasing stimulation frequency that did not differ
between CuA and CuD groups. Changes in the stimulation
frequency (0.1-0.5 Hz) did not affect the prolongation in TPS and
TR90 values in CuD and CuA rats (data not shown). One CuD
cell did not respond at 5 Hz and therefore the data from that cell was
omitted. Unstimulated (resting) CL measurements obtained before
initiation of the 0.1-Hz stimulus were used as the CL measurements for
the entire frequency sequence. All PS values were normalized to the PS
at 0.1 Hz (as control). These data suggest that intracellular
Ca2+ storage and release are likely preserved in copper
deficiency.
|
Effect of extracellular Ca2+ on
myocyte shortening.
The effect of extracellular Ca2+ on myocyte shortening is
shown in Fig. 4. Increases in
extracellular Ca2+ concentration from 0.5-3 mM caused
no significant effect on myocyte shortening in either the CuA or CuD
groups. Note that the absence of a significant difference between the
CuD and CuA cells at 1 mM Ca2+ (where Fig. 1B
suggests that there should be a difference) is likely due to the lower
sample number required to test for the effect of Ca2+.
|
Intracellular Ca2+ transients.
We used the membrane-permeant form of fura 2-AM to evaluate the
properties of intracellular Ca2+ transients in myocytes
from CuA and CuD rats. The time course of the fluorescent signal decay
was well described by a single exponential equation, and
was used
as a measure of the rate of decline of free cytoplasmic
Ca2+. The fluorescence measurements revealed that the
resting Ca2+ level was unchanged by the copper status.
However, the intracellular Ca2+ transients decayed at a
much faster rate in myocytes from the CuD group than from the CuA group
(see Fig. 5). The traces and graphs in
Fig. 5 were chosen to illustrate that copper deficiency caused no
change in the resting Ca2+ ratio other than a smaller
value.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study reports for the first time the direct impact of copper deficiency on ventricular function at the single myocyte level. Our results indicate that compromised ventricular function in copper deficiency is not likely due to depressed contractile performance of the single myocyte. The major mechanical alterations observed in CuD cardiac myocytes are characterized by enhanced cell shortening and decreased duration, as well as increased velocities of both shortening and relengthening. Furthermore, the increased rate of Ca2+ decay is consistent with the enhanced cell shortening and decreased duration of relengthening (which are described by TR90 values). Altered E-C coupling could contribute to these alterations in several ways, including increased sarcolemmal Ca2+, sarcoendoplasmic reticulum ATPase, Na+/Ca2+ exchange, or myofilament Ca2+ sensitivity.
Despite the improved function of individual cells, impaired mechanical function is an important characteristic of CuD hearts. Overt mechanical abnormalities of copper deficiency are commonly seen in whole hearts and the severity of the dysfunctions increases with time. Among the mechanisms that have been postulated for cardiac dysfunction from dietary copper deficiency is the reduced activity of copper-dependent lysyl oxidase. Lysyl oxidase initiates cross linking of elastin and collagen (22), which are involved in the structural integrity of the musculature. Reduced activity of this enzyme is associated with morphological and functional changes such as tissue flaccidity, aneurisms, and rupture of the heart, which are seen in whole hearts of CuD animals and may thus counteract the improved performance of individual cells.
The reduction of several copper-dependent and -independent antioxidant enzymes in copper deficiency has suggested that oxidative stress may contribute to altered cardiac function (23). Visual indications of damage and enhancement of lipid peroxidation have been observed in CuD hearts (3, 19). However, because peroxidation is generally a destructive process, it is difficult to visualize it as a direct cause of the improved contractile function observed in single myocytes. Indeed, in another prooxidant environment (diabetes), contractile function of individual cardiomyocytes is decreased (21). Thus although oxidative damage may explain structural changes in the CuD heart, it is necessary to look elsewhere for the cause of enhanced function of individual CuD myocytes.
Recent evidence has also suggested that titin may play a role in the alteration of myocardial function and development of heart dysfunction (9). Decreased internal stiffness of CuD cardiac myocytes along with an increase in myocyte diameter (7), presumably via an alteration in actin, myosin, titin, or other intracellular proteins, may allow a greater myocyte contraction to occur. Therefore it would be intriguing to determine the relative abundance of actin, myosin, and titin, which is an endosarcomeric elastic protein that potentially functions as a bidirectional spring in both shortening and relengthening of unloaded cardiac myocytes (8), and to evaluate the roles of these proteins in the altered mechanical function of CuD rat hearts.
Measurement of contractile performance in isolated myocytes has been established to provide a fundamental assessment of cardiac contractile function in pathological states; in this case, dietary copper deficiency. However, as in any study of this nature, caution must be taken when correlating our present cellular findings to whole heart function, because the latter is composed of heterogeneous cell types (including nerve terminals and fibroblasts) as well as the connective tissue alluded to earlier. Although we do not believe that copper deficiency led to skewed selection of cells, such factors as altered self-attachment of cells to the coverslips and differential sensitivity of the myocardium to collagenase digestion should be considered as possible contributing factors that may affect the results of this study.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Gwen Dahlen and Peter Leary for expert technical assistance in tissue copper measurement.
| |
FOOTNOTES |
|---|
This study was supported in part by the North Dakota Experimental Program to Stimulate Competitive Research (ND EPSCoR) and the US Department of Agriculture, Agricultural Research Service.
The US Department of Agriculture, Agriculture Research Service, Northern Plains Area, is an equal opportunity/affirmative action employer and all agency services are available without discrimination. Mention of a trademark or proprietary product does not constitute a guarantee or warranty of the product by the U.S. Department of Agriculture and does not imply its approval to the exclusion of other products that may also be suitable.
Address for reprint requests and other correspondence: J. Ren, Dept. of Pharmacology, Physiology, and Therapeutics, Univ. of North Dakota School of Medicine, 501 N. Columbia Rd., Grand Forks, ND 58203 (E-mail: jren{at}medicine.nodak.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 8 November 2000; accepted in final form 9 March 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Allen, CB,
and
Saari JT.
Isolated hearts from copper-deficient rats exhibit improved postischemic contractile performance.
J Nutr
123:
1794-1800,
1993.
2.
Borg, TK,
Klevay LM,
Gay RE,
Siegel R,
and
Bergin ME.
Alteration of the connective tissue network of striated muscle in copper deficient rats.
J Mol Cell Cardiol
17:
1173-1183,
1985[Web of Science][Medline].
3.
Chen, Y,
Saari JT,
and
Kang YJ.
Weak antioxidant defenses make the heart a target for damage in copper-deficient rats.
Free Radic Biol Med
17:
529-536,
1994[Web of Science][Medline].
4.
Davidson, J,
Medeiros DM,
and
Hamlin RL.
Cardiac ultrastructural and electrophysiological abnormalities in postweanling copper-restricted and copper-repleted rats in the absence of hypertrophy.
J Nutr
122:
1566-1575,
1992.
5.
Farquharson, C,
and
Robins SP.
Immunolocalization of collagen types I, III, and IV, elastin, and fibronectin within the heart of normal and copper-deficient rats.
J Comp Pathol
104:
245-255,
1991[Web of Science][Medline].
6.
Gorsuch, TT.
The Destruction of Organic Matter. Elmsford, NY: Pergamon, 1970, p. 28-39.
7.
Heller, LJ,
Morhman DE,
and
Prohaska JR.
Decreased passive stiffness of cardiac myocytes and cardiac tissue from copper-deficient rat hearts.
Am J Physiol Heart Circ Physiol
278:
H1840-H1847,
2000
8.
Helmes, M,
Trombitas K,
and
Granzier H.
Titin develops restoring force in rat cardiac myocytes.
Circ Res
79:
619-626,
1996
9.
Hsu, K,
Tsai CH,
Chiang FT,
Lo HM,
Tseng CD,
Wang SM,
Chen CF,
and
Tseng YZ.
Myocardial mechanics and titin in experimental insulin-resistant rats.
Jpn Heart J
38:
717-728,
1997[Medline].
10.
Huang, W,
Lai C,
Wang Y,
Askari A,
Klevay LM,
and
Chiu TH.
Altered expressions of cardiac Na/K-ATPase isoforms in copper deficient rats.
Cardiovasc Res
29:
563-568,
1995[Web of Science][Medline].
11.
Jalili, T,
Medeiros DM,
and
Wildman REC
Aspects of cardiomyopathy are exacerbated by elevated dietary fat in copper-restricted rats.
J Nutr
126:
807-816,
1996.
12.
Johnson, WT,
and
Kramer TR.
Effect of copper deficiency on erythrocyte membrane proteins of rats.
J Nutr
117:
1085-1090,
1987.
13.
Lear, PM,
and
Prohaska JR.
Atria and ventricles of copper-deficient rats exhibit similar hypertrophy and similar altered biochemical characteristics.
Proc Soc Exp Biol Med
215:
377-385,
1997[Medline].
14.
Medeiros, DM,
Bagby D,
Ovecka G,
and
McCormick R.
Myofibrillar, mitochondrial, and valvular morphological alterations in cardiac hypertrophy among copper-deficient rats.
J Nutr
121:
815-824,
1991.
15.
Medeiros, DM,
Shiry L,
Lincoln AJ,
and
Prochaska LJ.
Cardiac nonmyofibrillar proteins in copper-deficient rats: amino acid sequencing and Western blotting of altered proteins.
Biol Trace Elem Res
36:
271-282,
1993.
16.
Nielsen, FH,
Zimmerman TJ,
and
Shuler TR.
Interactions among nickel, copper, and iron in rats: liver and plasma contents of lipids and trace elements.
Biol Trace Elem Res
4:
125-143,
1982.
17.
Prohaska, JR.
Biochemical changes in copper deficiency.
J Nutr Biochem
1:
452-461,
1990.
18.
Prohaska, JR,
and
Heller LJ.
Mechanical properties of the copper-deficient rat heart.
J Nutr
112:
2142-2150,
1982.
19.
Redman, RS,
Fields M,
Reiser S,
and
Smith JC.
Dietary fructose exacerbates the cardiac abnormalities of copper deficiency in rats.
Atherosclerosis
74:
203-214,
1988[Web of Science][Medline].
20.
Ren, J.
Altered cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from BB spontaneously diabetic rats.
Cardiovasc Res
46:
162-171,
2000
21.
Ren, J,
and
Davidoff AJ.
Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes.
Am J Physiol Heart Circ Physiol
272:
H148-H158,
1997
22.
Rucker, RB,
Kosonen T,
Clegg MS,
Mitchell AE,
Rucker BR,
Uriu-Hare JY,
and
Keen CL.
Copper, lysyl oxidase, and extracellular matrix protein cross-linking.
Am J Clin Nutr
67, Suppl:
996-1002,
1998.
23.
Saari, JT.
Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration.
Can J Physiol Pharmacol
78:
848-855,
2000[Web of Science][Medline].
24.
Saari, JT,
Bode AM,
and
Dahlen GM.
Defects of copper deficiency in rats are modified by dietary treatments that affect glycation.
J Nutr
125:
2925-2934,
1995.
25.
Saari, JT,
Reeves PG,
Noordewier B,
Hall CB,
and
Lukaski HC.
Cardiovascular but not renal effects of copper deficiency are inhibited by dimethyl sulfoxide.
Nutr Res
10:
467-477,
1990[Web of Science].
26.
Saari, JT,
and
Schuschke DA.
Cardiovascular effects of dietary copper deficiency.
Biofactors
10:
359-375,
1999[Web of Science][Medline].
27.
Werman, MJ,
and
David R.
Lysyl oxidase activity, collagen cross-links, and connective tissue ultrastructure in the heart of copper-deficient male rats.
J Nutr Biochem
7:
437-444,
1996[Web of Science].
This article has been cited by other articles:
![]() |
F. Dong, L. B. Esberg, Z. K. Roughead, J. Ren, and J. T. Saari Increased contractility of cardiomyocytes from copper-deficient rats is associated with upregulation of cardiac IGF-I receptor Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H78 - H84. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kan, Z. Xie, and M. S. Finkel p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes Am J Physiol Cell Physiol, January 1, 2004; 286(1): C1 - C7. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |